{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:15:20Z","timestamp":1790669720549,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T00:00:00Z","timestamp":1186012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> In 1997 the FDA approved the first double\u2010red\u2010blood\u2010cell (2RBC) collection device. Soon after, travel deferral for variant Creutzfeldt\u2010Jakob disease (vCJD) risk was adopted. To show the importance of including 2RBCs in predictive models of the blood supply, an existing whole\u2010blood (WB) model was updated to include 2RBC collection and then run to simulate the effect of vCJD deferral on total RBC availability.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The model simulates donation of allogeneic WB and 2RBCs, with donors stratified into eight age and sex groups. The model was updated with 2003 donation and economic data from 16 blood centers.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> The distribution of donations by demographic group differed both within and between WB and 2RBCs. Overall, 2RBC donation made up 24\u2003percent of transfusable RBC units, at a lower per\u2010unit <jats:italic>acquisition<\/jats:italic> cost from both the blood bank and the societal perspectives. Component fees from hospitals would alter this interpretation. The model predicts that vCJD travel deferral led to a 3.3\u2003percent (95% confidence interval [CI], 2.3\u20104.1) decrease in the total number of RBC units, which was more than offset by 2RBC collection, resulting in a 10.4\u2003percent (95% CI, 9.8%\u201011.1%) net increase in RBC units. Modeled 2RBC results match operational records, whereas vCJD deferral is overestimated.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> Shifting to 2RBC collection led to a substantial gain in available RBCs: even with policies that adversely affect the quantity of RBCs in the supply, 2RBC collection results in a net gain. The economics of 2RBC collection are not as clear, however.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2007.01426.x","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T01:15:53Z","timestamp":1186449353000},"page":"2025-2037","source":"Crossref","is-referenced-by-count":26,"title":["Modeling red cell procurement with both double\u2010red\u2010cell and whole\u2010blood collection and the impact of European travel deferral on units available for transfusion"],"prefix":"10.1111","volume":"47","author":[{"given":"Erin","family":"Madden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Custer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01128.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.11.005"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.331094054618.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.11.006"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00681.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1998.7530212.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1997.d01-78.x"},{"key":"e_1_2_6_9_2","first-page":"66S","article-title":"Improved red blood cell products: collection by apheresis","volume":"35","author":"Smith JW","year":"1995","journal-title":"Transfusion"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01224.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.11.007"},{"key":"e_1_2_6_12_2","first-page":"377","article-title":"Variant Creutzfeldt\u2010Jakob disease (vCJD): precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion","volume":"75","year":"2000","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X05280557"},{"key":"e_1_2_6_14_2","first-page":"14","volume-title":"Modern blood banking and transfusion practices.","author":"Wright PA","year":"1999"},{"key":"e_1_2_6_15_2","volume-title":"Guidelines for the organization of a blood transfusion service.","year":"1992"},{"key":"e_1_2_6_16_2","volume-title":"Consumer price index 2006 [monograph on the Internet].","year":"2006"},{"key":"e_1_2_6_17_2","volume-title":"National compensation survey [monograph on the Internet].","year":"2004"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03307.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199813040-00003"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200017050-00006"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.03.002"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2006.01.006"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04045.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.8.959"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2003.12.006"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00346.x"},{"key":"e_1_2_6_27_2","first-page":"59","article-title":"A policy analysis of major decisions relating to Creutzfeldt\u2010Jakob disease and the blood supply","volume":"165","author":"Wilson K","year":"2001","journal-title":"CMAJ"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2003.50007"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2001.00056.x"},{"key":"e_1_2_6_30_2","volume-title":"Guidance for industry revised preventative measures to reduce the possible risk of transmission of Creutzfeldt\u2010Jakob disease (CJD) and variant Creutzfeldt\u2010Jakob disease (vCJD) by blood and blood products.","year":"2002"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2007.01426.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2007.01426.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T06:29:35Z","timestamp":1697264975000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2007.01426.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,2]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1537-2995.2007.01426.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01426.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,2]]}}}